Barbara Weber, Chief Executive Officer at Tango Therapeutics, Inc. (TNGX), sold 18,791 shares at $2.99 ($58K) on 2025-02-04, disclosed to the SEC on 2025-02-06.
Open-market sale of $58k TNGX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 9,778 | $29K | 50.7% |
| 2 | $3.16 | 9,013 | $28K | 49.3% |
| Total | $3.07 avg | 18,791 | $58K | 100% |
| Filing → |
| TNGX | SELL | 2024-02-08 | $230K | — | Filing → |
| RVMD | SELL | 2023-09-06 | $526K | — | Filing → |
| RVMD | SELL | 2021-02-05 | $252K | — | Filing → |